The Impact of COVID-19 on the Optimal Management of Osteoporosis
10.11005/jbm.2021.28.2.115
- Author:
Sung Hye KONG
1
;
Bo Kwon HWANG
;
Byung-Ho YOON
Author Information
1. Department of Internal Medicine, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seoul, Korea
- Publication Type:Review Article
- From:Journal of Bone Metabolism
2021;28(2):115-122
- CountryRepublic of Korea
- Language:English
-
Abstract:
Osteoporosis does not take a break while Coronavirus disease 2019 (COVID-19) stunned and overtook everyone’s lives. Medical resources were immediately shifted, self-isolation and telemedicine were expanded, ambulatory care services such as bone densitometry and osteoporosis-centered clinics came to a near halt. Progress with fracture prevention has been challenged because osteoporotic fracture with low energy injury is more prevalent even though restriction of people’s movement. Thus we must re-engage with chronic bone health concerns and fracture prevention. This review discusses challenges in management of osteoporosis during the COVID-19 pandemic and reinforces the need to implementing recommendations concerning the importance of bone fragility care with at least those patients who are already treated with antiosteoporotic drugs maintaining their adherence to treatments.
